Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.

Kyrodimou M, Andreadis D, Drougou A, Amanatiadou EP, Angelis L, Barbatis C, Epivatianos A, Vizirianakis IS.

Clin Oral Investig. 2014 Jan;18(1):199-210. doi: 10.1007/s00784-013-0937-z. Epub 2013 Feb 22.

PMID:
23430339
2.

Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.

Kaur J, Sawhney M, DattaGupta S, Shukla NK, Srivastava A, Walfish PG, Ralhan R.

PLoS One. 2013 Jun 28;8(6):e67361. doi: 10.1371/journal.pone.0067361. Print 2013.

PMID:
23840677
3.

Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.

Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, Farah CS.

Oral Oncol. 2012 Oct;48(10):997-1006. doi: 10.1016/j.oraloncology.2012.05.011. Epub 2012 Jun 14.

PMID:
22704062
4.

Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.

Li YY, Zhou CX, Gao Y.

Oral Oncol. 2015 Oct;51(10):935-43. doi: 10.1016/j.oraloncology.2015.07.003. Epub 2015 Jul 17.

PMID:
26194050
5.

Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.

Wang L, Liu T, Wang Y, Cao L, Nishioka M, Aguirre RL, Ishikawa A, Geng L, Okada N.

Virchows Arch. 2007 Nov;451(5):959-66. Epub 2007 Sep 11.

PMID:
17846785
6.

Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.

Jiang Y, Liao L, Shrestha C, Ji S, Chen Y, Peng J, Wang L, Liao E, Xie Z.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9042-51. eCollection 2015.

PMID:
26464646
7.

Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.

Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ.

J Biol Chem. 2004 Aug 27;279(35):37191-200. Epub 2004 Jun 16.

PMID:
15205458
8.

Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia.

Ishida K, Ito S, Wada N, Deguchi H, Hata T, Hosoda M, Nohno T.

Mol Cancer. 2007 Oct 9;6:62.

PMID:
17922924
9.
10.

beta- and gamma-catenin expression in oral dysplasia.

Lo Muzio L, Lo Russo L, Falaschini S, Ciavarella D, Pentenero M, Arduino P, Favia G, Maiorano E, Rubini C, Pieramici T, Gandolfo S.

Oral Oncol. 2009 Jun;45(6):501-4. doi: 10.1016/j.oraloncology.2008.06.004. Epub 2008 Aug 19.

PMID:
18715817
11.

Concomitant loss of p120-catenin and β-catenin membrane expression and oral carcinoma progression with E-cadherin reduction.

Sasaya K, Sudo H, Maeda G, Kawashiri S, Imai K.

PLoS One. 2013 Aug 6;8(8):e69777. doi: 10.1371/journal.pone.0069777. Print 2013.

PMID:
23936352
12.

E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.

von Zeidler SV, de Souza Botelho T, Mendonça EF, Batista AC.

BMC Cancer. 2014 Dec 17;14:972. doi: 10.1186/1471-2407-14-972.

PMID:
25518919
13.

EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.

Cao W, Younis RH, Li J, Chen H, Xia R, Mao L, Chen W, Ren H.

Cancer Prev Res (Phila). 2011 Nov;4(11):1816-24. doi: 10.1158/1940-6207.CAPR-11-0130. Epub 2011 Jun 22.

PMID:
21697275
14.

Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.

Fang WK, Gu W, Liao LD, Chen B, Wu ZY, Wu JY, Shen J, Xu LY, Li EM.

Asian Pac J Cancer Prev. 2014;15(2):871-6.

PMID:
24568510
15.

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.

Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.

J Exp Clin Cancer Res. 2009 Feb 26;28:28. doi: 10.1186/1756-9966-28-28.

PMID:
19243631
16.

Beta- and gamma-catenin expression in oral squamous cell carcinomas.

Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF, De Rosa G.

Anticancer Res. 1999 Sep-Oct;19(5B):3817-26.

PMID:
10628318
17.

β-catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells.

Lee SS, Tsai CH, Tsai LL, Chou MC, Chou MY, Chang YC.

J Formos Med Assoc. 2012 Apr;111(4):194-200. doi: 10.1016/j.jfma.2010.11.002. Epub 2012 Mar 21.

PMID:
22526207
18.

Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.

Sanders DS, Blessing K, Hassan GA, Bruton R, Marsden JR, Jankowski J.

Mol Pathol. 1999 Jun;52(3):151-7.

PMID:
10621837
19.

Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.

Bagutti C, Speight PM, Watt FM.

J Pathol. 1998 Sep;186(1):8-16.

PMID:
9875134
20.

P120 catenin is associated with desmogleins when desmosomes are assembled in high-Ca2+ medium but not when disassembled in low-Ca2+ medium in DJM-1 cells.

Kanno M, Aoyama Y, Isa Y, Yamamoto Y, Kitajima Y.

J Dermatol. 2008 Jun;35(6):317-24. doi: 10.1111/j.1346-8138.2008.00480.x.

PMID:
18578707
Items per page

Supplemental Content

Write to the Help Desk